Skip to main content
Log in

Radioembolisation for treatment of pediatric hepatocellular carcinoma

  • Work in Progress
  • Published:
Pediatric Radiology Aims and scope Submit manuscript

Abstract

Transarterial radioembolisation with yttrium-90 (TARE-Y90), a catheter-directed therapy, has been used extensively in adults to treat primary and secondary hepatic malignancies. To our knowledge, the use of this palliative technique has not been described in children. We present two children with unresectable hepatocellular carcinoma (HCC) treated with TARE-Y90.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Donnelly L (2009) Pediatric imaging: the fundamentals. Saunders Elsevier, Philadelphia

    Google Scholar 

  2. Gupta AA, Gerstle JT, Ng V et al (2011) Critical review of controversial issues in the management of advanced pediatric liver tumors. Pediatr Blood Cancer 56:1013–1018

    Article  PubMed  Google Scholar 

  3. Katzenstein HM, Krailo MD, Malogolowkin MH et al (2002) Hepatocellular carcinoma in children and adolescents: results from the Pediatric Oncology Group and the Children’s Cancer Group intergroup study. J Clin Oncol 20:2789–2797

    Article  PubMed  Google Scholar 

  4. Kennedy AS, McNeillie P, Dezarn WA et al (2009) Treatment parameters and outcome in 680 treatments of internal radiation with resin 90Y-microspheres for unresectable hepatic tumors. Int J Radiat Oncol Biol Phys 74:1494–1500

    Article  PubMed  CAS  Google Scholar 

  5. National Cancer Institute Childhood Liver Cancer Treatment (PDQ®) (2012) http://www.cancer.gov/cancertopics/pdq/treatment/childliver/HealthProfessional/. Accessed 26 October 2012

  6. Lewandowski RJ, Geschwind JF, Liapi E et al (2011) Transcatheter intraarterial therapies: rationale and overview. Radiology 259:641–657

    Article  PubMed  Google Scholar 

  7. D’Avola D, Lnarrairaegui M, Bilbao JI et al (2009) A retrospective comparative analysis of the effect of Y90-radioembolization on the survival of patients with unresectable hepatocellular carcinoma. Hepatogastroenterology 56:1683–1688

    PubMed  Google Scholar 

  8. Lewandowski RJ, Kulik LM, Riaz A et al (2009) A comparative analysis of transarterial downstaging for hepatocellular carcinoma: chemoembolization versus radioembolization. Am J Transplant 9:1920–1928

    Article  PubMed  CAS  Google Scholar 

  9. Salem R, Lewandowski RJ, Mulcahy MF et al (2010) Radioembolization for hepatocellular carcinoma using Yttrium-90 microspheres: a comprehensive report of long-term outcomes. Gastroenterology 138:52–64

    Article  PubMed  CAS  Google Scholar 

  10. Czauderna P, Mackinlay G, Perilongo G et al (2002) Hepatocellular carcinoma in children: results of the first prospective study of the International Society of Pediatric Oncology group. J Clin Oncol 20:2798–2804

    Article  PubMed  CAS  Google Scholar 

  11. Salem R, Lewandowski RJ, Atassi B et al (2005) Treatment of unresectable hepatocellular carcinoma with use of 90Y microspheres (TheraSphere): safety, tumor response, and survival. J Vasc Interv Radiol 16:1627–1639

    Article  PubMed  Google Scholar 

  12. Goin JE, Salem R, Carr BI et al (2005) Treatment of unresectable hepatocellular carcinoma with intrahepatic yttrium 90 microspheres: factors associated with liver toxicities. J Vasc Interv Radiol 16:205–213

    Article  PubMed  Google Scholar 

  13. Yang CW, Yen HH, Su WW et al (2010) Profound transient thrombocytopenia associated with 90Yttrium microsphere therapy for inoperable hepatoma. South Med J 103:1264–1268

    Article  PubMed  Google Scholar 

  14. Salem R, Lewandowski RJ, Kulik L et al (2011) Radioembolization results in longer time-to-progression and reduced toxicity compared with chemoembolization in patients with hepatocellular carcinoma. Gastroenterology 140:497–507

    Article  PubMed  Google Scholar 

  15. Carr BI, Kondragunta V, Buch SC et al (2010) Therapeutic equivalence in survival for hepatic arterial chemoembolization and yttrium 90 microsphere treatments in unresectable hepatocellular carcinoma: a two-cohort study. Cancer 116:1305–1314

    Article  PubMed  CAS  Google Scholar 

  16. Kooby DA, Egnatashvili V, Srinivasan S et al (2010) Comparison of yttrium-90 radioembolization and transcatheter arterial chemoembolization for the treatment of unresectable hepatocellular carcinoma. J Vasc Interv Radiol 21:224–230

    Article  PubMed  Google Scholar 

  17. Salem R, Lewandowski RJ, Gates VL et al (2011) Research reporting standards for radioembolization of hepatic malignancies. J Vasc Interv Radiol 22:265–278

    Article  PubMed  Google Scholar 

Download references

Conflicts of interest

None

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Clifford Matthew Hawkins.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hawkins, C.M., Kukreja, K., Geller, J.I. et al. Radioembolisation for treatment of pediatric hepatocellular carcinoma. Pediatr Radiol 43, 876–881 (2013). https://doi.org/10.1007/s00247-012-2568-y

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00247-012-2568-y

Keywords

Navigation